Travel Times to Facilities Offering Oral Medication Therapy for COVID-19

This quality improvement study evaluates access to oral COVID-19 therapeutics within communities in the 48 contiguous states and the District of Columbia.

Detalles Bibliográficos
Autores principales: Kahn, Peter A., Ying, Xiaohan, Mathis, Walter S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857170/
https://www.ncbi.nlm.nih.gov/pubmed/36595298
http://dx.doi.org/10.1001/jamanetworkopen.2022.49810
Descripción
Sumario:This quality improvement study evaluates access to oral COVID-19 therapeutics within communities in the 48 contiguous states and the District of Columbia.

Ejemplares similares